Company profile

Retinai company profile

RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning. RetinAI has proprietary technology that provides unforeseen image quality enhancement, as well as automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies and device manufacturers at similar level of performance as a human would produce.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2016-12-16

Headquarters

Headquarters
Bulle, Fribourg, Switzerland
Postal code
3010
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
8
Total equity funding
$16.7M
Last funding
Series B / $7.8M / 2024-10-16
Last equity funding
Series B / $7.8M
Investors
8
Lead investors
5
Founders
3
Articles
66
Exited on
2025-10-15

Founders and investors

Founders

Carlos CillerSandro ZanetStefanos Apostolopoulos

Lead investors

EurostarsMatterwave VenturesSanoptisTopcon HealthcareVenture Kick

Investors

b2ventureMatterwave VenturesVenture KickVerve VenturesZürcher Kantonal Bank

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.